-
-
-
-
-
-
-
Entasis Therapeutics Holdings Inc. (ETTX) Begins Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

